285 related articles for article (PubMed ID: 32411776)
1. Prognostic value of the albumin-bilirubin grade in patients with hepatocellular carcinoma and other liver diseases.
Feng D; Wang M; Hu J; Li S; Zhao S; Li H; Liu L
Ann Transl Med; 2020 Apr; 8(8):553. PubMed ID: 32411776
[TBL] [Abstract][Full Text] [Related]
2. Incorporating albumin-bilirubin grade into the cancer of the liver Italian program system for hepatocellular carcinoma.
Chan AW; Chong CC; Mo FK; Wong J; Yeo W; Johnson PJ; Yu S; Lai PB; Chan AT; To KF; Chan SL
J Gastroenterol Hepatol; 2017 Jan; 32(1):221-228. PubMed ID: 27257086
[TBL] [Abstract][Full Text] [Related]
3. Integration of albumin-bilirubin (ALBI) score into Barcelona Clinic Liver Cancer (BCLC) system for hepatocellular carcinoma.
Chan AW; Kumada T; Toyoda H; Tada T; Chong CC; Mo FK; Yeo W; Johnson PJ; Lai PB; Chan AT; To KF; Chan SL
J Gastroenterol Hepatol; 2016 Jul; 31(7):1300-6. PubMed ID: 26751608
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma.
Hiraoka A; Kumada T; Michitaka K; Toyoda H; Tada T; Ueki H; Kaneto M; Aibiki T; Okudaira T; Kawakami T; Kawamura T; Yamago H; Suga Y; Miyamoto Y; Tomida H; Azemoto N; Mori K; Miyata H; Ninomiya T; Kawasaki H
J Gastroenterol Hepatol; 2016 May; 31(5):1031-6. PubMed ID: 26647219
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Modified Child-pugh (MCP), Albumin-bilirubin (ALBI), and Child-pugh (CP) score for predicting of survival in Hepatocellular Carcinoma Patients Treated with Transcatheter Arterial Chemoembolization.
Liu Y; Cheng C; Zhou H; Hu S; Wang H; Xie Q; Lei L; Wang P; Liu G; Hu H
Bull Cancer; 2021 Oct; 108(10):931-939. PubMed ID: 34247763
[TBL] [Abstract][Full Text] [Related]
6. Modified CLIP score with the albumin-bilirubin grade retains prognostic value in HBV-related hepatocellular carcinoma patients treated with trans-catheter arterial chemoembolization therapy.
Cai XR; Chen ZH; Liu MM; Lin JX; Zhang XP; Chen J; Lin Q; Ma XK; Wen JY; Xie SD; Wu XY; Dong M
J Cancer; 2018; 9(13):2380-2388. PubMed ID: 30026834
[No Abstract] [Full Text] [Related]
7. Validation and Potential of Albumin-Bilirubin Grade and Prognostication in a Nationwide Survey of 46,681 Hepatocellular Carcinoma Patients in Japan: The Need for a More Detailed Evaluation of Hepatic Function.
Hiraoka A; Michitaka K; Kumada T; Izumi N; Kadoya M; Kokudo N; Kubo S; Matsuyama Y; Nakashima O; Sakamoto M; Takayama T; Kokudo T; Kashiwabara K; Kudo M
Liver Cancer; 2017 Nov; 6(4):325-336. PubMed ID: 29234636
[TBL] [Abstract][Full Text] [Related]
8. Applicability of albumin-bilirubin-based Japan integrated staging score in hepatitis B-associated hepatocellular carcinoma.
Chan AW; Chong CC; Mo FK; Wong J; Yeo W; Johnson PJ; Yu S; Lai PB; Chan AT; To KF; Chan SL
J Gastroenterol Hepatol; 2016 Oct; 31(10):1766-1772. PubMed ID: 26992142
[TBL] [Abstract][Full Text] [Related]
9. Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization.
Ananchuensook P; Sriphoosanaphan S; Suksawatamnauy S; Siripon N; Pinjaroen N; Geratikornsupuk N; Kerr SJ; Thanapirom K; Komolmit P
BMC Gastroenterol; 2022 Jun; 22(1):295. PubMed ID: 35701739
[TBL] [Abstract][Full Text] [Related]
10. Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Analysis.
Hiraoka A; Kumada T; Kudo M; Hirooka M; Koizumi Y; Hiasa Y; Tajiri K; Toyoda H; Tada T; Ochi H; Joko K; Shimada N; Deguchi A; Ishikawa T; Imai M; Tsuji K; Michitaka K;
Dig Dis; 2017; 35(6):602-610. PubMed ID: 29040999
[TBL] [Abstract][Full Text] [Related]
11. Albumin-Bilirubin (ALBI) Grade as Part of the Evidence-Based Clinical Practice Guideline for HCC of the Japan Society of Hepatology: A Comparison with the Liver Damage and Child-Pugh Classifications.
Hiraoka A; Kumada T; Kudo M; Hirooka M; Tsuji K; Itobayashi E; Kariyama K; Ishikawa T; Tajiri K; Ochi H; Tada T; Toyoda H; Nouso K; Joko K; Kawasaki H; Hiasa Y; Michitaka K;
Liver Cancer; 2017 Jun; 6(3):204-215. PubMed ID: 28626732
[TBL] [Abstract][Full Text] [Related]
12. Newly Proposed ALBI Grade and ALBI-T Score as Tools for Assessment of Hepatic Function and Prognosis in Hepatocellular Carcinoma Patients.
Hiraoka A; Kumada T; Michitaka K; Kudo M
Liver Cancer; 2019 Oct; 8(5):312-325. PubMed ID: 31768342
[TBL] [Abstract][Full Text] [Related]
13. Survival Analysis Using Albumin-Bilirubin (ALBI) Grade for Patients Treated with Drug-Eluting Embolic Transarterial Chemoembolization for Hepatocellular Carcinoma.
Young LB; Tabrizian P; Sung J; Biederman D; Bishay VL; Ranade M; Patel RS; Nowakowski FS; Fischman AM; Lookstein RA; Kim E
J Vasc Interv Radiol; 2022 May; 33(5):510-517.e1. PubMed ID: 35150838
[TBL] [Abstract][Full Text] [Related]
14. Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation.
Oh IS; Sinn DH; Kang TW; Lee MW; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Dig Dis Sci; 2017 Nov; 62(11):3235-3242. PubMed ID: 28983724
[TBL] [Abstract][Full Text] [Related]
15. Comparison between Child-Pugh score and Albumin-Bilirubin grade in the prognosis of patients with HCC after liver resection using time-dependent ROC.
Zhao S; Wang M; Yang Z; Tan K; Zheng D; Du X; Liu L
Ann Transl Med; 2020 Apr; 8(8):539. PubMed ID: 32411762
[TBL] [Abstract][Full Text] [Related]
16. Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma.
Wang YY; Zhong JH; Su ZY; Huang JF; Lu SD; Xiang BD; Ma L; Qi LN; Ou BN; Li LQ
Br J Surg; 2016 May; 103(6):725-734. PubMed ID: 27005482
[TBL] [Abstract][Full Text] [Related]
17. Using the Albumin-Bilirubin (ALBI) grade as a prognostic marker for radioembolization of hepatocellular carcinoma.
Mohammadi H; Abuodeh Y; Jin W; Frakes J; Friedman M; Biebel B; Choi J; El-Haddad G; Kis B; Sweeney J; Hoffe S
J Gastrointest Oncol; 2018 Oct; 9(5):840-846. PubMed ID: 30505583
[TBL] [Abstract][Full Text] [Related]
18. Validation of Modified ALBI Grade for More Detailed Assessment of Hepatic Function in Hepatocellular Carcinoma Patients: A Multicenter Analysis.
Hiraoka A; Kumada T; Tsuji K; Takaguchi K; Itobayashi E; Kariyama K; Ochi H; Tajiri K; Hirooka M; Shimada N; Ishikawa T; Tachi Y; Tada T; Toyoda H; Nouso K; Joko K; Hiasa Y; Michitaka K; Kudo M
Liver Cancer; 2019 Mar; 8(2):121-129. PubMed ID: 31019902
[TBL] [Abstract][Full Text] [Related]
19. Validation of modified albumin-bilirubin-TNM score as a prognostic model to evaluate patients with hepatocellular carcinoma.
Elshaarawy O; Alkhatib A; Elhelbawy M; Gomaa A; Allam N; Alsebaey A; Rewisha E; Waked I
World J Hepatol; 2019 Jun; 11(6):542-552. PubMed ID: 31293722
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Role of Albumin, Bilirubin, and ALBI Scores: Analysis of 1000 Patients with Hepatocellular Carcinoma Undergoing Radioembolization.
Antkowiak M; Gabr A; Das A; Ali R; Kulik L; Ganger D; Moore C; Abecassis M; Katariya N; Mouli S; Mahalingam D; Lewandowski RJ; Salem R; Riaz A
Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31238514
[No Abstract] [Full Text] [Related]
[Next] [New Search]
